Status:

UNKNOWN

Effect of Ketamine/Midazolam Premedication Versus Pre-extubation Ketofol on Recovery Profile in Pediatrics Undergoing Adenotonsillectomy.

Lead Sponsor:

Cairo University

Conditions:

Emergence Delirium

Eligibility:

All Genders

3-10 years

Phase:

PHASE4

Brief Summary

An optimum recovery profile after AT includes a rapid, smooth awakening without emergence agitation (EA), stable vital signs and oxygenation, reduced postoperative nausea and vomiting (PONV), controll...

Eligibility Criteria

Inclusion

  • ASA physical status I or II
  • Children scheduled for AT under general anesthesia (GA).

Exclusion

  • Congenital cardiovascular anomalies
  • Behavioral changes
  • Delayed physical development
  • Children receiving sedatives or anticonvulsants therapy

Key Trial Info

Start Date :

August 25 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT06010927

Start Date

August 25 2023

End Date

December 1 2023

Last Update

September 15 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Abeer Ahmed

Maadi, Cairo Governorate, Egypt, 11562

2

Anesthesia department - Faculty of medicine- Cairo University

Cairo, Egypt

Effect of Ketamine/Midazolam Premedication Versus Pre-extubation Ketofol on Recovery Profile in Pediatrics Undergoing Adenotonsillectomy. | DecenTrialz